Subclinical thyroid disease in elderly subjects

Acta Biomedica

Volumn 81, Issue SUPPL. 1, 2010, Pages 31-36

  Ceresini, Graziano ^a   Morganti, Simonetta ^a   Maggio, Marcello ^a   Usberti, Elisa ^a   Fiorino, Ilaria ^a   Artoni, Andrea ^a   Teresi, Giulio ^a   Belli, Serena ^a   Ridolfi, Valentina ^a   Valenti, Giorgio ^a   Ceda, Gian Paolo ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Aging; Subclinical thyroid disease

Indexed keywords

THYROID HORMONE;

AGED; BLOOD; BONE REMODELING; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; REVIEW;

AGED; BONE REMODELING; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; THYROID HORMONES;

EID: 77954912771     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Ceresini G, Lauretani F, Maggio M, et al. Evaluation of thyroid function over the life span and of the relationship between subclinical hyperthyroidism and cognitive impairment in the elderly. Results from the InCHIANTI study. J Am Geriat Soc 2009; 57(1): 89-93.
2. Mariotti S, Franceschi C, Cossarizza A, Pinchera A. The aging thyroid. Endocr Rev 1995; 16: 686-715.
3. Hershman JM, Pekary AE, Berg L, Solomon DH, Sawin CT. Serum thyrotropin and thyroid hormone levels in elderly and middle-aged euthyroid persons. J Am Geriatr Soc 1993; 41: 823-8.
4. Hoogendoorn EH, Hermus AR, de Vegt F, et al. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem 2006; 52: 104-11.
5. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-99.
6. Donda A, Lemarchand-Berau T. Aging alters the activity of 50 deiodinase in the adenohypophysis, thyroid gland, and liver of the male rat. Endocrinology 1989; 124: 1305-9.
7. Lewis GF, Alessi CA, Imperial JG, Refetoff S. Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression. J Clin Endocrinol Metab 1991; 73: 843-49.
8. Mariotti S, Barbesino G, Caturegli P, et al. Complex alteration of thyroid function in healthy centenarians. J Clin Endocrinol Metab 1993; 77: 1130-4.
9. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disease in the community: a twentyyear follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43: 55-68.
10. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526-34.
11. Sawin CT, Chopra D, Azizi F, Mannix JE, Bacharach P. The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly. JAMA 1979; 242: 247-50.
12. TunbridgeWM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977; 7: 481-93.
13. Bemben DA, Winn P, Hamm RM, Morgan L, Davis A, Barton E. Thyroid disease in the elderly. Part 1. Prevalence of undiagnosed hypothyroidism. J Fam Pract 1994; 38: 577-82.
14. Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS. Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy. JAMA 1987; 258: 209-13.
15. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004; 292: 2591-9.
16. Laurberg P, Andersen S, Bulow Pedersen I, Carle A. Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment. Drugs Aging 2005; 22: 23-38.
17. Karlin NJ, Weintraub N, Chopra IJ. Current controversies in endocrinology: screening of asymptomatic elderly for subclinical hypothyroidism. J Am Med Dir Assoc 2004; 5: 333-8.
18. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001; 344: 501-9.
19. Biondi B, Fazio S, Palmieri EA, et al. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 1999; 84: 2064-7.
20. Brenta G, Mutti LA, Schnitman M, Fretes O, Pezzone A, Matute ML. Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy. Am J Cardiol 2003; 91: 1327-30.
21. Di Bello V, Monzani F, Giorgi D, et al. Ultrasonic myocardial textural analysis in subclinical hypothyroidism. J Am Soc Echocardiogr 2000; 13: 832-40.
22. Vitale G, Galderisi M, Lupoli, et al. Left ventricular myocardial impairment in subclinical hypothyroidism assessed by a new ultrasound tool: pulsed tissue Doppler. J Clin Endocrinol Metab 2002; 87: 4350-5.
23. Monzani F, Di Bello V, Caraccio N, et al. Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebocontrolled study. J Clin Endocrinol Metab 2001; 86: 1110-5.
24. Yazici M, Gorgulu S, Sertbas Y, et al. Effects of thyroxin therapy on cardiac function in patients with subclinical hypothyroidism: index of myocardial performance in the evaluation of left ventricular function. Int J Cardiol 2004; 95: 135-43.
25. Aghini-Lombardi F, Di Bello V, Talini E, et al. Early textural and functional alterations of left ventricular myocardium in mild hypothyroidism. Eur J Endocrinol 2006; 155: 3-9.
26. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure. Part II: causal mechanisms and treatment. Circulation 2002; 105: 1503-8.
27. Bough EW, Crowley WF, Ridgway EC, et al. Myocardial function in hypothyroidism: relation to disease severity and response to treatment. Arch Intern Med 1978; 138: 1476-80.
28. Foldes J, Istvanfy M, Halmagyi H, Varadi A, Gara A, Partos O. Hypothyroidism and the heart. Examination of left ventricular function in subclinical hypothyroidism. Acta Med Hung 1987; 44: 337-47.
29. Tseng KH, Walfish PG, Persand JA, Gilbert BW. Concurrent aortic and mitral valve echocardiography permits measurement of systolic time intervals as an index of peripheral tissue thyroid function status. J Clin Endocrinol Metab 1987; 69: 633-8.
30. Staub JJ, Althaus BU, Engler H, et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992; 92: 631-42.
31. TunbridgeWM, Evered DC, Hall R, et al. Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf) 1977; 7: 495-508.
32. Hueston WJ, Pearson WS. Subclinical hypothyroidism and the risk of hypercholesterolemia. Ann Fam Med 2004; 2: 351-5.
33. Lindeman RD, Schade DS, LaRue A, et al. Subclinical hypothyroidism in a biethnic, urban community. J Am Geriatr Soc 1999; 47: 703-9.
34. Samuels MH. Subclinical thyroid disease in the elderly. Thyroid 1998; 8: 803-13.
35. Billewicz WZ, Chapman RS, Crooks J, et al. Statistical methods applied to the diagnosis of hypothyroidism. Q J Med 1969; 38: 255-66.
36. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Consensus Statement #1: Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab 2005; 90: 581-5.
37. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228-8.
38. van den Beld AW, Visser TJ, Feelders RA, Grobbee DE, Lamberts SW Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J Clin Endocrinol Metab 2005; 90: 6403-9.
39. Psaty BM, Anderson M, Kronmal RA, et al. The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: the Cardiovascular Health Study. J Am Geriatr Soc 2004; 52: 1639-47.
40. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocrine Rev 2008; 29: 76-131.
41. Cooper DS Thyroid disease in the oldest old: the exception to the rule. JAMA 2004; 292: 2651-4.
42. Cooper DS Approach to the patient with subclinical hyperthyroidism. J Clin Endocrinol Metab 2007; 92: 3-9.
43. Biondi B, Palmieri EA, Klain M, Schlumberger M, Filetti S, Lombardi G. Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol 2005; 152: 1-9.
44. Ross DS Subclinical thyrotoxicosis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott, Williams and Wilkins 2000;1016-1020
45. Papi G, Pearce EN, Braverman LE, Betterle C, Roti E. A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only. Am J Med 2005; 118: 349-61.
46. Biondi B, Filetti S, Schlumberger M. Thyroid hormone therapy and thyroid cancer: a reassessment. Nat Clin Pract Endocrinol Metab 2005; 1: 32-40.
47. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16: 109-42.
48. Cooper DS. Hyperthyroidism. Lancet 2003; 362: 459-68.
49. Toft AD. Clinical practice. Subclinical hyperthyroidism. N Engl J Med 2001; 345: 512-6.
50. Marqusee E, Haden ST, Utiger RD. Subclinical thyrotoxicosis. Endocrinol Metab Clin North Am 1998; 27: 37-49.
51. Aghini-Lombardi F, Antonangeli L, Martino E, et al. The spectrum of thyroid disorders in an iodine deficient community: the Pescopagano survey. J Clin Endocrinol Metab 1999; 84: 561-6.
52. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331: 1249-52.
53. Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006; 295: 1033-41.
54. Toh SH, Claunch BC, Brown PH. Effect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med 1985; 145: 883-6.
55. Rosen CJ, Adler RA. Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J Clin Endocrinol Metab 1992; 75: 1531-4.
56. Foldes J, Tarjan G, Szathmary M, Varga F, Krasznai I, Horvath C. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is the thyroid status a risk factor for osteoporosis? Clin Endocrinol (Oxf) 1993; 39: 521-7.
57. Kalmijn S, Mehta KM, Pols HAP. et al. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam Study. Clin Endocrinol 2000; 53: 733-7.
58. Roberts LM, Pattison H, Roalfe A, et al. Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? Ann Intern Med 2006; 145: 573-81.
59. Cooper DS. Subclinical thyroid disease: a clinician's perspective. Ann Intern Med 1998; 129: 135-8.
60. Clinical guideline, part 1. Screening for thyroid disease. American College of Physicians. Ann Intern Med 1998; 129: 141-3.